Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advair vs Serevent for COPD Exacerbations Post-Hospitalization
NCT01110200Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2010
- Primary completion
- Apr 2012
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 4 trial of salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Apr 2010; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01110200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01110200.